- Home
- PBYI vs RANG Comparison
PBYI vs RANG Comparison
Compare PBYI & RANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- RANG
- Stock Information
- Founded
- PBYI 2010
- RANG 2024
- Country
- PBYI United States
- RANG United States
- Employees
- PBYI N/A
- RANG N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- RANG
- Sector
- PBYI Health Care
- RANG
- Exchange
- PBYI Nasdaq
- RANG Nasdaq
- Market Cap
- PBYI 154.1M
- RANG N/A
- IPO Year
- PBYI N/A
- RANG 2024
- Fundamental
- Price
- PBYI $3.14
- RANG $10.03
- Analyst Decision
- PBYI Strong Buy
- RANG
- Analyst Count
- PBYI 1
- RANG 0
- Target Price
- PBYI $7.00
- RANG N/A
- AVG Volume (30 Days)
- PBYI 418.2K
- RANG 19.9K
- Earning Date
- PBYI 05-01-2025
- RANG 01-01-0001
- Dividend Yield
- PBYI N/A
- RANG N/A
- EPS Growth
- PBYI 37.78
- RANG N/A
- EPS
- PBYI 0.62
- RANG N/A
- Revenue
- PBYI $230,468,000.00
- RANG N/A
- Revenue This Year
- PBYI N/A
- RANG N/A
- Revenue Next Year
- PBYI $3.27
- RANG N/A
- P/E Ratio
- PBYI $5.06
- RANG N/A
- Revenue Growth
- PBYI N/A
- RANG N/A
- 52 Week Low
- PBYI $2.23
- RANG $9.91
- 52 Week High
- PBYI $6.06
- RANG $10.64
- Technical
- Relative Strength Index (RSI)
- PBYI 45.33
- RANG N/A
- Support Level
- PBYI $3.14
- RANG N/A
- Resistance Level
- PBYI $3.56
- RANG N/A
- Average True Range (ATR)
- PBYI 0.19
- RANG 0.00
- MACD
- PBYI -0.05
- RANG 0.00
- Stochastic Oscillator
- PBYI 17.54
- RANG 0.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.